Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1981 1
1984 2
1985 1
1989 1
1990 2
1991 1
1993 2
1994 2
1995 1
1996 3
1997 4
1998 2
1999 4
2000 3
2001 5
2002 2
2003 3
2004 4
2005 4
2006 5
2007 7
2008 3
2009 2
2010 8
2011 6
2012 7
2013 5
2014 9
2015 8
2016 7
2017 9
2018 8
2019 7
2020 11
2021 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

146 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Inherited skin tumor"
Page 1
Neurofibromatosis type 1: a multidisciplinary approach to care.
Hirbe AC, Gutmann DH. Hirbe AC, et al. Lancet Neurol. 2014 Aug;13(8):834-43. doi: 10.1016/S1474-4422(14)70063-8. Lancet Neurol. 2014. PMID: 25030515 Free article. Review.
Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high predisposition to develop both benign and malignant tumours. ...As our understanding of this disorder deepens through basic laboratory and clinical investigations, swift impleme …
Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high predisposition to develop both benign and ma …
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
Craiglow BG, Boyden LM, Hu R, Virtanen M, Su J, Rodriguez G, McCarthy C, Luna P, Larralde M, Humphrey S, Holland KE, Hogeling M, Hidalgo-Matlock B, Ferrari B, Fernandez-Faith E, Drolet B, Cordoro KM, Bowcock AM, Antaya RJ, Ashack K, Ashack RJ, Lifton RP, Milstone LM, Paller AS, Choate KA. Craiglow BG, et al. J Am Acad Dermatol. 2018 Sep;79(3):487-494. doi: 10.1016/j.jaad.2018.02.034. Epub 2018 Mar 1. J Am Acad Dermatol. 2018. PMID: 29477734 Free PMC article.
In addition, these eruptions are often recalcitrant to conventional psoriasis therapies such as methotrexate, oral retinoids, and tumor necrosis factor-alpha inhibitors. OBJECTIVE: We sought to describe the clinical characteristics, family history, and response to t …
In addition, these eruptions are often recalcitrant to conventional psoriasis therapies such as methotrexate, oral retinoids, and tumor …
Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis.
Rao L, Wu L, Liu Z, Tian R, Yu G, Zhou Z, Yang K, Xiong HG, Zhang A, Yu GT, Sun W, Xu H, Guo J, Li A, Chen H, Sun ZJ, Fu YX, Chen X. Rao L, et al. Nat Commun. 2020 Sep 30;11(1):4909. doi: 10.1038/s41467-020-18626-y. Nat Commun. 2020. PMID: 32999291 Free PMC article.
Also, cancer cells secrete stimulating factors, which polarize tumor-associated macrophages from an antitumor M1 phenotype to a tumorigenic M2 phenotype. ...These properties, combined with the capabilities inherited from source cells, make hNVs an attractive immunot …
Also, cancer cells secrete stimulating factors, which polarize tumor-associated macrophages from an antitumor M1 phenotype to a tumor …
Natural history study of patients with familial platelet disorder with associated myeloid malignancy.
Cunningham L, Merguerian M, Calvo KR, Davis J, Deuitch NT, Dulau-Florea A, Patel N, Yu K, Sacco K, Bhattacharya S, Passi M, Ozkaya N, De Leon S, Chong S, Craft K, Diemer J, Bresciani E, O'Brien K, Andrews EJ, Park N, Hathaway L, Cowen EW, Heller T, Ryan K, Barochia A, Nghiem K, Niemela J, Rosenzweig S, Young DJ, Frischmeyer-Guerrerio PA, Braylan R, Liu PP. Cunningham L, et al. Blood. 2023 Dec 21;142(25):2146-2158. doi: 10.1182/blood.2023019746. Blood. 2023. PMID: 37738626
Our results highlight the importance of a multidisciplinary approach, early malignancy detection, and wider awareness of inherited disorders. This actively accruing, longitudinal study will genotype and phenotype more patients with FPDMM, which may lead to a better underst …
Our results highlight the importance of a multidisciplinary approach, early malignancy detection, and wider awareness of inherited di …
Epidermolysis bullosa: Advances in research and treatment.
Prodinger C, Reichelt J, Bauer JW, Laimer M. Prodinger C, et al. Exp Dermatol. 2019 Oct;28(10):1176-1189. doi: 10.1111/exd.13979. Epub 2019 Aug 8. Exp Dermatol. 2019. PMID: 31140655 Free PMC article. Review.
Epidermolysis bullosa (EB) is the umbrella term for a group of rare inherited skin fragility disorders caused by mutations in at least 20 different genes. ...We are evaluating immunotherapy using an anti-PD1 monoclonal antibody as a palliative treatment option for l …
Epidermolysis bullosa (EB) is the umbrella term for a group of rare inherited skin fragility disorders caused by mutations in …
Reticulate hyperpigmentation.
Schnur RE, Heymann WR. Schnur RE, et al. Semin Cutan Med Surg. 1997 Mar;16(1):72-80. doi: 10.1016/s1085-5629(97)80038-7. Semin Cutan Med Surg. 1997. PMID: 9125768 Review.
In addition to reticulate hyperpigmentation, mucosal leukoplakia, bone marrow dysfunction, cytogenetic instability, and a predisposition to malignancy are characteristic of DKC. The most common pattern of inheritance is X-linked, with heterozygous females showing variable …
In addition to reticulate hyperpigmentation, mucosal leukoplakia, bone marrow dysfunction, cytogenetic instability, and a predisposition to …
Skin gene therapy for acquired and inherited disorders.
Carretero M, Escámez MJ, Prada F, Mirones I, García M, Holguín A, Duarte B, Podhajcer O, Jorcano JL, Larcher F, Del Río M. Carretero M, et al. Histol Histopathol. 2006 Nov;21(11):1233-47. doi: 10.14670/HH-21.1233. Histol Histopathol. 2006. PMID: 16874666 Review.
Therefore, the re-expression of the normal counterpart should be sufficient to reverse phenotype in single-gene inherited disorders. A growing number of candidate diseases are being evaluated since the ADA deficiency was selected for the first approved human gene therapy …
Therefore, the re-expression of the normal counterpart should be sufficient to reverse phenotype in single-gene inherited disorders. …
Apoptosis and pathogenesis of melanoma and nonmelanoma skin cancer.
Erb P, Ji J, Kump E, Mielgo A, Wernli M. Erb P, et al. Adv Exp Med Biol. 2008;624:283-95. doi: 10.1007/978-0-387-77574-6_22. Adv Exp Med Biol. 2008. PMID: 18348464 Review.
UV-light can randomly induce DNA damage in keratinocytes, but it can also mutate genes essential for control and surveillance in the skin epidermis. ...This occurs under the control of the p53 suppressor gene. Fas-ligand (FasL), a member of the tumor necrosis …
UV-light can randomly induce DNA damage in keratinocytes, but it can also mutate genes essential for control and surveillance in the …
Intestinal microbiota-related effects on graft-versus-host disease.
Shono Y, Docampo MD, Peled JU, Perobelli SM, Jenq RR. Shono Y, et al. Int J Hematol. 2015 May;101(5):428-37. doi: 10.1007/s12185-015-1781-5. Epub 2015 Mar 27. Int J Hematol. 2015. PMID: 25812838 Free PMC article. Review.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an increasingly important treatment for conditions including hematopoietic malignancies and inherited hematopoietic disorders, and is considered to be the most effective form of tumor immunotherapy av …
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an increasingly important treatment for conditions including hematopoietic …
Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice.
Hicks JK, Howard R, Reisman P, Adashek JJ, Fields KK, Gray JE, McIver B, McKee K, O'Leary MF, Perkins RM, Robinson E, Tandon A, Teer JK, Markowitz J, Rollison DE. Hicks JK, et al. JCO Precis Oncol. 2021 May 20;5:PO.20.00513. doi: 10.1200/PO.20.00513. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34095711 Free PMC article. Review.
Herein, we focus on the clinical perspective of integrating NGS results into patient care to assist with therapeutic decision making. ...Several of these key considerations center on informatics tools that support NGS test ordering and referencing back to the results for t …
Herein, we focus on the clinical perspective of integrating NGS results into patient care to assist with therapeutic decision making. …
146 results